Vanguard Group’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Hold |
363,720
| – | – | ﹤0.01% | 3704 |
|
|
2025
Q1 | $1.29M | Hold |
363,720
| – | – | ﹤0.01% | 3632 |
|
|
2024
Q4 | $1.16M | Hold |
363,720
| – | – | ﹤0.01% | 3714 |
|
|
2024
Q3 | $1.33M | Hold |
363,720
| – | – | ﹤0.01% | 3684 |
|
|
2024
Q2 | $1.7M | Hold |
363,720
| – | – | ﹤0.01% | 3610 |
|
|
2024
Q1 | $3.2M | Sell |
363,720
-1,614
| -0.4% | -$14.2K | ﹤0.01% | 3446 |
|
|
2023
Q4 | $1.56M | Sell |
365,334
-2,120
| -0.6% | -$9.07K | ﹤0.01% | 3686 |
|
|
2023
Q3 | $1.25M | Hold |
367,454
| – | – | ﹤0.01% | 3752 |
|
|
2023
Q2 | $2.07M | Hold |
367,454
| – | – | ﹤0.01% | 3640 |
|
|
2023
Q1 | $1.77M | Hold |
367,454
| – | – | ﹤0.01% | 3720 |
|
|
2022
Q4 | $2.22M | Buy |
367,454
+135
| +0% | +$815 | ﹤0.01% | 3624 |
|
|
2022
Q3 | $1.76M | Hold |
367,319
| – | – | ﹤0.01% | 3795 |
|
|
2022
Q2 | $2.1M | Hold |
367,319
| – | – | ﹤0.01% | 3786 |
|
|
2022
Q1 | $2.63M | Sell |
367,319
-1,385
| -0.4% | -$9.9K | ﹤0.01% | 3847 |
|
|
2021
Q4 | $2.94M | Buy |
368,704
+97,884
| +36% | +$781K | ﹤0.01% | 3878 |
|
|
2021
Q3 | $3.03M | Buy |
270,820
+1,391
| +0.5% | +$15.5K | ﹤0.01% | 3910 |
|
|
2021
Q2 | $3.93M | Buy |
269,429
+10,282
| +4% | +$150K | ﹤0.01% | 3713 |
|
|
2021
Q1 | $4.7M | Buy |
+259,147
| New | +$4.7M | ﹤0.01% | 3563 |
|